A randomized pilot trial was performed to evaluate the feasibility of administration of glutathione (GSH, 1200 mg, i.v.) as a protector in preventing diarrhea in patients operated on for endometrial cancer and submitted to adjuvant radiotherapy of the pelvis. Diarrhea occurred In 52% of patients In the untreated control group and only in 28% of patients In the GSH-treated group. Our preliminary data indicate that GSH administered before radiotherapy reduced the occurrence of diarrhea from oxidative damage to the intestinal mucosa. A large-scale phase III study is required to obtain definitive conclusions on the protective potential of GSH.
Get full access to this article
View all access options for this article.
References
1.
CornellJ.S., MeisterA.: Glutathione and gamma-glutamyl cycle enzymes in crypt and villus tip cells of rat jejunal mucosa.Proc. Natl. Acad. Sci., 73: 420–422, 1976.
2.
GreenN.: The avoidance of small intestinal injury in gynecological cancer.J. Radiat. Biol. Phys., 9: 1385–1390, 1983.
3.
JensenG.L., MeisterA.: Radioprotection of human lymphoid cells by exogenously supplied glutathione is mediated by gamma-glutamyl transpeptidase.Proc. Natl. Acad. Sci., 50: 4714–4717, 1983.
4.
OgasawaraT., HoenschH., OhnhausE.E.: Distribution of glutathione and its related enzymes in small intestinal mucosa of rats.Arch. Toxicol. Suppl., 8: 110–113, 1985.
5.
OiryJ., PueJ.Y., ImbachJ.L., FatomeM., Sentenac-RoumanouM., LionC.: Synthesis and radioprotective activity of new cysteamine and cystamine derivatives.J. Med. Chem., 29: 2217–2225, 1986.
6.
PotishR.A.: Prediction of radiation-related small bowel damage.Radiology, 135: 219–221, 1980.
7.
ReveszL., MalaiseE.P.: Significance of cellular glutathione in radioprotection and repair of radiation damage. In: Functions of Glutathione: Biochemical, Physiological, Toxicological and Clinical Aspects.LarssonA., OrreniusM.D., HolmgrenA., MannervikB. (Eds.), pp. 163–173, Raven Press, New York, 1983.
8.
SaezG.T., BannisterW.H., BannisterJ.V.: Free radicals and thiol compounds. The role of glutathione against free radical toxicity. In: Glutathione Metabolism and Physiological Function.VinaJ. (Ed.), pp. 228–252, CRC Press, Boca Raton, 1990.
9.
SchofieldP.F., CarrN.D., HoldenD.: Pathogenesis and treatment of radiation bowel disease.J. R. Soc. Med., 79: 30–22, 1986.
10.
SiegersC.P., Bose-YounesH., ThiesE., HoppenkampsR., YounesM.: Glutathione and GSH-dependent enzymes in the tumorous and nontumorous mucosa of the human colon and rectum.J. Cancer Res. Clin. Oncol., 107: 328–341, 1984.
11.
SmolukG.D., FaheyR.C., Calabro-JonesP.M., AguileraJ.A., WardJ.F.: Radioprotection of cells in culture by WR-2721 and derivatives: form of the drug responsible for protection.Cancer Res., 48: 3641–3647, 1988.
12.
SmolukG.D., FaheyR.C., WardJ.F.: Interaction of glutathione and other low-molecular-weight thiols with DNA: evidence for counterion condensation and coion depletion near DNA.Radiat. Res., 114: 3–10, 1988.
13.
TavaniE., TedeschiM., TognellaS., FiumiM., DragoneA.: Glutathione and gamma-GT activity in normal and neoplastic tissues. In: Conference Proceedings, Strategies in Cancer Medical Therapy, Riccione, April 12, 1980.
14.
ThomasJ.P., MaiorinoM., UrsiniF., GirottiR.W.: Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation.J. Biol. Chem., 265: 454–461, 1990.
15.
Van BladerenP.J.: Formation of toxic metabolites from drugs and other xenobiotics by glutathione conjugation.Trans. Pharmacol. Sci., 9: 295–299, 1988.
16.
WendelA.: Glutathione peroxidase. In: Enzymatic Basis of Detoxification.JakobyW.B. (Ed.), pp. 333–353, Academic Press, New York, 1980.
